Allergan Results Showcase Botox Growth: Physicians Capitalize through IAPAM’s Symposium
05/14/2011

The IAPAM predicts strong growth in botox and dermal filler services in 2011, supported by recent results published by Allergan, the makers of Botox. Physicians who incorporate these procedures, such as Botox treatments, into their practices, will reap significant reward in 2011.

Online PR News – 14-May-2011 – – Las Vegas, NV, May 13, 2011 -- The IAPAM’s goal is to provide industry-leading education for physicians by offering the field’s most comprehensive, hands-on, aesthetic training, including: the Aesthetic Medicine Symposium with Botox Training, The IAPAM’s Exclusive Physician hCG Training, Botox Training, Dermal Filler Training, Advanced Filler Training, and Chemical Peel Training.

The IAPAM’s Aesthetic Medicine Symposium with Botox Training (http://www.aestheticmedicinesymposium.com) trains physicians on how to profitably add aesthetic medicine procedures, from botox to physician-directed skin care, to their practices. The Symposium with Botox Training covers all of the ASPS’s Top 5 Minimally Invasive Procedures:

Botox (5,379,360)
Soft Tissue Fillers (1,773,328)
Chemical Peel (1,114,865)
Laser hair removal (937,602)
Microdermabrasion (824,706)

The profitability of adding these procedures to a practice is supported by Allergan’s recently announced 1Q 2011 results. Botox enjoyed strong growth, “increasing 10.1% in dollars and 8.7% in local currencies versus the prior year, with good growth stemming from both the therapeutic and aesthetic businesses,” shared Chairman and CEO of Allergan, Inc., David Pyott. “Regarding BOTOX Cosmetic, we are pleased that the U.S. market seems to be growing around the mid-teens in units….[and] we estimate that in Q4 2010, that we enjoyed approximately worldwide 80% market share of the total neuromodulator market.”

Spectacular Growth in Facial Aesthetics Market

This demand translated to a “spectacular” 48.5% growth, in the entire facial aesthetics market. Coupled with the demand for Botox, Pyott commented that “it would seem that the dermal filler market is growing very strongly worldwide with more consumers entering the market given the comfort of the latest generation of lidocaine-containing hyaluronic acid products and more syringes being used per face. At the leading medical conventions around the world, there are increasing numbers of papers and symposia on the use of dermal fillers, especially for volumizing.”

IAPAM’s Symposium with Botox Training Helps Physicians Capture this Market

Jeff Russell, Executive Director of the IAPAM (http://www.iapam.com), offers his analysis on the Allergan results. “As supported by the first quarter successes of Allergan’s suite of aesthetic medicine products: Botox, Juvederm and Latisse, it appears that people are putting more invasive procedures like facelifts on hold. Such cosmetic surgical options are down 28.9%. Conversely, more economical ‘liquid facelifts,’ using botulinum toxin products (Botox & Dysport) and dermal fillers (Juvederm, Restylane, and Perlane), have grown significantly in popularity,” reflects Russell.

To assist physicians, “the IAPAM’s Aesthetic Medicine Symposium with Botox Training, has garnered great praise from the physicians who have attended,” shares Russell. He also sees the benefits in offering complementary medical weight management (hCG for weight loss) and aesthetic medicine treatments to patients.

To capture this market growth, over 800 physicians, as well as their accompanying medspa managers, registered nurses, and assistants, have attended the IAPAM’s training programs. To register for an upcoming training session, please contact the IAPAM, at 1-800-219-5108 ext. 704, or visit http://www.iapam.com or http://www.aestheticmedicinesymposium.com.

Botox and Juvederm are trademarks of Allergan, Inc. Dysport, Restylane, and Perlane are trademarks of Medicis, Inc.

About the IAPAM: The International Association for Physicians in Aesthetic Medicine (IAPAM)

The International Association for Physicians in Aesthetic Medicine is a voluntary global association of physicians and supporters, which sets standards for the aesthetic medical profession worldwide. The goal of the association is to offer education, ethical standards, credentialing, and member benefits to members around the globe. IAPAM membership is open to all licensed medical doctors (MDs), doctors of osteopathic medicine (DOs), physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: Botox training, medical aesthetic training, laser training, physician hCG training, and aesthetic practice business training. Additional information about the association can be accessed through the IAPAM’s website (http://www.iapam.com) or by contacting:

Jeff Russell, Executive-Director, International Association for Physicians in Aesthetic Medicine (IAPAM), 1-800-219-5108 ext. 704, info@theiapam.com

Contact:
Jeff Russell
Executive-Director
IAPAM
848 N. Rainbow Blvd., #713
Las Vegas, NV 89107
1-800-219-5108 x704
info@theiapam.com
http://www.aestheticmedicinesymposium.com